Alessandro Riva will lead Glenmark Pharmaceuticals’ new innovation company – to be based in Paramus – as chief executive officer, effective April 2.

Dion Rooney will lead the organization of technology and digital transformation for the Parsippany-based company.

A cluster of 26 hepatitis A cases among homeless individuals and/or drug users has prompted the New Jersey Department of Health to supply hundreds of vaccines to southern county health departments to immunize at-risk uninsured or underinsured individuals.

U.S. Sens. Bob Menendez and Cory Booker announced the Metropolitan Family Health Network Inc. received $3,359,718 in federal funding from the U.S. Department of Health and Human Services to continue the essential health care services they provide to underserved communities.

Rep. Chris Smith and Rep. Thomas Suozzi introduced legislation Tuesday to bolster efforts to combat the opioid epidemic by cracking down on the production and import of fentanyl made in China.

East Brunswick native Scott Gottlieb, the commissioner of the Food and Drug Administration, announced he would resign from his position at the end of the month.

Little Falls-based Cantel Medical Corp. announced on Tuesday that George Fotiades has been named the company’s president and chief executive officer. In a press release, Cantel said that Fotiades would continue to serve on the company’s board of directors. Fotiades succeeds Jorgen Hansen, who resigned. Charles Diker, chairman of the Cantel Board, said in a statement, ...

Senate Bill 3172 would have the State Board of Education revise the core curriculum standards in Health and Physical Education to include instruction in suicide prevention and mental health in elementary through high school.